Gastroenterology Research and Practice / 2013 / Article / Fig 1

Research Article

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo

Figure 1

Inhibition of NET-1 mRNA and protein expression by NET-1shRNA in HCC cells line MHCC97H cells. (a) RT-QPCR showed NET-1shRNA resulted in 49% reduction of NET-1 mRNA levels, when compared with untreated group. (b) Western blot showed the intensities of NET-1 protein and GAPDH protein in these three groups. (c) Image J analyzed NET-1shRNA resulted in 51% reduction of NET-1 protein levels, when compared with untreated group (** ).
685150.fig.001a
(a)
685150.fig.001b
(b)
685150.fig.001c
(c)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.